Think you’re immune from IRA implications because your drug wasn’t selected?
The IRA affects all pharma manufacturers, not only the companies with a drug in question. That’s because reducing the price of an expensive drug will have a ripple effect on all competitive drugs. Preventing revenue leakage while remaining confidently compliant is just as critical for you as it is for the manufacturers currently entrenched in the IRA negotiation process. You can master the complexities involved with pricing, contracts, discounts and audit trails. This eBook will show how to get on the right path to compliance.